$CBT

Keohane Sean D sold $11.5M of CBT

Keohane Sean D (President and CEO) sold 134,895 shares of CABOT CORP (CBT) at $85.00 ($11.47M total) on 2026-08-28.

Original reporting
SEC EDGAR · Keohane Sean D
Published Aug 31, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 31, 2026, 11:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CBT
Bearish
medium confidence
Mentioned
$CBT
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBTBearishLow
01

Why it matters

The CEO's $11.5M share sale reduces insider ownership, which may affect investor sentiment.

02

Market read

Primary insider transaction that could influence short‑term price action.

03

What to watch

Sale could be part of a pre‑arranged liquidity event unrelated to company outlook.

Relevance 7/10Novelty 7/10Timing: post‑market filing 2026‑08‑31

Background

Cabot Corp (CBT) is an energy and specialty chemicals producer listed on NYSE.

Company-level read

Ticker impact

$CBTBearishMedium confidence
Context

CEO Sean D. Keohane sold 134,895 shares for $11.5M, reducing his stake to 404,134 shares.

Expected impact

Potential short-term dip of 2‑4% as market digests the sale.

Evidence & confidence

Form 4 is a primary source; the $11.5M sale by the CEO is material for a mid‑cap stock.

Market effects

Minimal impact on the oil & gas sector beyond CBT.

U.S. market only; no broader regional effect.

Limited to investors tracking insider activity.

Counterpoint

Insider may be diversifying; sale does not necessarily indicate negative fundamentals.

Key entities

  • Cabot Corp

    Energy and chemicals producer, ticker CBT.

  • Sean D. Keohane

    President and CEO of Cabot Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBTMedAI 8/10

Cabot’s New US$350 Million Bond Issue Might Change The Case For Investing In CBT

Cabot Corporation issued US$350 million in senior unsecured notes due 2029, altering its funding mix. The move may impact investor views on balance sheet flexibility, especially as earnings have softened. Q3 2026 results showed US$6 million net income on US$982 million sales, with full-year EPS guidance of US$2.77. The company projects US$4.0 billion revenue and US$479.7 million earnings by 2029.

$CBTMed

Cabot Corporation Q3 2026 Earnings Call Summary

Cabot Corp reported Q3 2026 results driven by a 19% year-over-year EBIT rise in Performance Chemicals. Reinforcement Materials saw lower gross profit per ton despite 5% higher volumes, tied to 2026 tire customer agreement headwinds. Adjusted EPS guidance for FY2026 was tightened to $6.15–$6.45, and Cabot plans a $125 million brownfield battery capacity expansion. CEO transition is planned.

$CBTMed

Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth

Cabot Corp (CBT) reported Q3 fiscal 2026 earnings call highlights, citing growth in Performance Chemicals and battery materials. Reinforcement Materials EBIT fell to $97 million from $128 million year over year, with a modest Q4 sequential decline expected. The company expects Performance Chemicals margins to normalize as raw material costs catch up to Q3 pricing. It updated its FY2026 tax rate to 28% to 30% and said it plans to resume buybacks in Q4.